HIV-1/parasite co-infection and the emergence of new parasite strains

Parasitology

Volumn 135, Issue 7, 2008, Pages 795-806

  Lloyd Smith, James O ^a   Poss, Mary ^a   Grenfell, Bryan T ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Drug resistance; Emerging infectious diseases; HIV AIDS; Immunosuppression; Mathematical model; Population heterogeneity; Zoonosis

Indexed keywords

DRUG RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; LEISHMANIA; LEISHMANIASIS; MALARIA; MATHEMATICAL MODEL; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PARASITE TRANSMISSION; PARASITOSIS; PLASMODIUM; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; STRONGYLOIDES; STRONGYLOIDIASIS; TRYPANOSOMA; TRYPANOSOMIASIS; ZOONOSIS;

ANIMALS; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV-1; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIASIS; MALARIA; MALE; MATHEMATICS; PARASITIC DISEASES; POPULATION DYNAMICS; PREVALENCE; SCHISTOSOMIASIS; TRYPANOSOMIASIS; VIRULENCE; WORLD HEALTH;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 46249098805     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182008000292     Document Type: Review

References (51)

1. Abu-Raddad, L. J., Patnaik, P. and Kublin, J. G. (2006). Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314, 1603-1606.
2. Ambroise-Thomas, P. (2001). Parasitic diseases and immunodeficiencies. Parasitology 122, S65-S71.
3. Anderson, R. M. and May, R. M. (1991). Infectious Diseases of Humans: Dynamics and Control, Oxford University Press, UK.
4. Andre, J. B. and Day, T. (2005). The effect of disease life history on the evolutionary emergence of novel pathogens. Proceedings of the Royal Society B-Biological Sciences 272, 1949-1956.
5. Antia, R., Regoes, R. R., Koella, J. C. and Bergstrom, C. T. (2003). The role of evolution in the emergence of infectious diseases. Nature 426, 658-661.
6. Becker, N. and Marschner, I. (1990). The effect of heterogeneity on the spread of disease. In Stochastic Processes in Epidemic Theory, Vol. 86 (eds. Picard, P., Gabriel, J. P. and Lefevre, C.), pp. 90-103. Springer-Verlag, New York.
7. Brown, M., Mawa, P. A., Kaleebu, P. and Elliott, A. M. (2006). Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunology 28, 613-623.
8. Butcher, G. A. (2005). T-cell depletion and immunity to malaria in HIV-infections. Parasitology 130, 141-150.
9. Chicharro, C. and Alvar, J. (2003). Lower trypanosomatids in HIV/AIDS patients. Annals of Tropical Medicine and Parasitology 97, 75-78.
10. Chicharro, C., Jimenez, M. I. and Alvar, J. (2003). Iso-enzymatic variability of Leishmania infantum in Spain. Annals of Tropical Medicine and Parasitology 97, 57-64.
11. Corbett, E. L., Steketee, R. W., ter Kuile, F. O., Latif, A. S., Kamali, A. and Hayes, R. J. (2002). HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 359, 2177-2187.
12. Croft, S. L., Sundar, S. and Fairlamb, A. H. (2006). Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19, 111-126.
13. Cross, P. C., Lloyd-Smith, J. O., Johnson, P. L. F. and Getz, W. M. (2005). Duelling timescales of host movement and disease recovery determine invasion of disease in structured populations. Ecology Letters 8, 587-595.
14. Davies, S. J., Grogan, J. L., Blank, R. B., Lim, K. C., Locksley, R. M. and McKerrow, J. H. (2001). Modulation of blood fluke development in the liver by hepatic CD4(+) lymphocytes. Science 294, 1358-1361.
15. Desjeux, P. and Alvar, J. (2003). Leishmania/HIV co-infections : epidemiology in Europe. Annals of Tropical Medicine and Parasitology 97, 3-15.
16. Diekmann, O. and Heesterbeek, J. A. P. (2000). Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis, and Interpretation, John Wiley & Sons, Chichester.
17. Doenhoff, M. J., Hassounah, O., Murare, H., Bain, J. and Lucas, S. (1986). The schistosome egg granuloma - immunopathology in the cause of host protection or parasite survival. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 503-514.
18. French, N., Nakiyingi, J., Lugada, E., Watera, C., Whitworth, J. A. G. and Gilks, C. F. (2001). Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 15, 899-906.
19. Graham, A. L., Cattadori, I. M., Lloyd-Smith, J. O., Ferrari, M. J. and Bjornstad, O. N. (2007). Transmission consequences of coinfection: cytokines writ large? Trends in Parasitology 23, 284-291.
20. Gramiccia, M. (2003). The identification and variability of the parasites causing leishmaniasis in HIV-positive patients in Italy. Annals of Tropical Medicine and Parasitology 97, 65-73.
21. Gupta, S., Swinton, J. and Anderson, R. M. (1994). Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proceedings of the Royal Society of London Series B-Biological Sciences 256, 231-238.
22. Harms, G. and Feldmeier, H. (2005). The impact of HIV infection on tropical diseases. Infectious Disease Clinics of North America 19, 121-135.
23. Harris, T. E. (1963). The Theory of Branching Processes, Springer, Berlin.
24. Kaare, M., Picozzi, K., Mlengeya, T., Fèvre, E., Mellau, L., Mtambo, M., Cleaveland, S. and Welburn, S. (2007). Sleeping sickness - A re-emerging disease in the Serengeti? Travel Medicine and Infectious Disease 5, 117-124.
25. Kibona, S. N., Matemba, L., Kaboya, J. S. and Lubega, G. W. (2006). Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Tropical Medicine and International Health 11, 144-155.
26. Korenromp, E. L., Williams, B. G., de Vlas, S. J., Gouws, E., Gilks, C. F., Ghys, P. D. and Nahlen, B. L. (2005). Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerging Infectious Diseases 11, 1410-1419.
27. Laguna, F. (2003). Treatment of leishmaniasis in HIV-positive patients. Annals of Tropical Medicine and Parasitology 97, 135-142.
28. Legros, D., Evans, S., Maiso, F., Enyaru, J. C. K. and Mbulamberi, D. (1999). Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 439-442.
29. Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E. and Getz, W. M. (2005). Superspreading and the effect of individual variation on disease emergence. Nature 438, 355-359.
30. Mathis, A., Weber, R. and Deplazes, P. (2005). Zoonotic potential of the microsporidia. Clinical Microbiology Reviews 18, 423-445.
31. Matovu, E., Seebeck, T., Enyaru, J. C. K. and Kaminsky, R. (2001). Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes and Infection 3, 763-770.
32. Mermin, J., Lule, J., Ekwaru, J. P., Downing, R., Hughes, P., Bunnell, R., Malamba, S., Ransom, R., Kaharuza, F., Coutinho, A., Kigozi, A. and Quick, R. (2005). Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS 19, 1035-1042.
33. Molina, R., Gradoni, L. and Alvar, J. (2003). HIV and the transmission of Leishmania. Annals of Tropical Medicine and Parasitology 97, 29-45.
34. Pieniazek, N. J., Bornay-Llinares, F. J., Slemenda, S. B., da Silva, A. J., Moura, I. N. S., Arrowood, M. J., Ditrich, O. and Addiss, D. G. (1999). New Cryptosporidium genotypes in HIV-infected persons. Emerging Infectious Diseases 5, 444-449.
35. Porco, T. C., Small, P. M. and Blower, S. M. (2001). Amplification dynamics: Predicting the effect of HIV on tuberculosis outbreaks. Journal of Acquired Immune Deficiency Syndromes 28, 437-444.
36. Pratlong, F., Dereure, J., Deniau, M., Marty, P., Faraut-Gambarelli, F. and Dedet, J. P. (2003). Enzymatic polymorphism during Leishmania/HIV co-infection: a study of 381 Leishmania strains received between 1986 and 2000 at the international cryobank in Montpellier, France. Annals of Tropical Medicine and Parasitology 97, 47-56.
37. Redhu, N. S., Dey, A., Balooni, V. and Singh, S. (2006). Leishmania-HIV co-infection : an emerging problem in India. AIDS 20, 1213-1214.
38. Secor, W. E. (2006). Interactions between schistosomiasis and infection with HIV-1. Parasite Immunology 28, 597-603.
39. Taylor, H. M. and Karlin, S. (1998). An Introduction to Stochastic Modeling, 3 edn. Academic Press, San Diego.
40. Ter Kuile, F. O., Parise, M. E., Verhoeff, F. H., Udhayakumar, V., Newman, R. D., Van Eijk, A. M., Rogerson, S. J. and Steketee, R. W. (2004). The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene 71, 41-54.
41. UNAIDS (2006). Report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS, Geneva.
42. Van Geertruyden, J. P., Mulenga, M., Mwananyanda, L., Chalwe, V., Moerman, F., Chilengi, R., Kasongo, W., Van Overmeir, C., Dujardin, J. C., Colebunders, R., Kestens, L. and D'Alessandro, U. (2006). HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. Journal of Infectious Diseases 194, 917-925.
43. Viney, M. E., Brown, M., Omoding, N. E., Bailey, J. W., Gardner, M. P., Roberts, E., Morgan, D., Elliott, A. M. and Whitworth, J. A. G. (2004). Why does HIV infection not lead to disseminated strongyloidiasis? Journal of Infectious Diseases 190, 2175-2180.
44. White, N. J. (2004). Antimalarial drug resistance. Journal of Clinical Investigation 113, 1084-1092.
45. Whitworth, J. (2006). Malaria and HIV. In HIV InSite Knowledge Base, Vol. 2007 (eds. Peiperl, L., Coffey, S., Bacon, O. and Voberding, P.), URL http://hivinsite.ucsf.edu/InSite?page=k6-05-04-0. (Accessed Oct 14, 2007). UCSF Center for HIV Information, San Francisco.
46. Whitworth, J., Morgen, D., Quigley, M., Smith, A., Mayanja, S., Eotu, H., Omoding, N., Okongo, M., Malamba, S. and Ojwiya, A. (2000). Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356, 1051-1056.
47. Williams, B. G. and Dye, C. (2003). Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301, 1535-1537.
48. Williams, B. G., Korenromp, E. L., Gouws, E., Schmid, G. P., Auvert, B. and Dye, C. (2006). HIV infection, Antiretroviral therapy, and CD4(+) cell count distributions in African populations. Journal of Infectious Diseases 194, 1450-1458.
49. Woolhouse, M. E. J., Dye, C., Etard, J. F., Smith, T., Charlwood, J. D., Garnett, G. P., Hagan, P., Hii, J. L. K., Ndhlovu, P. D., Quinnell, R. J., Watts, C. H., Chandiwana, S. K. and Anderson, R. M. (1997). Heteropeneities in the transmission of infectious agents Implications for the design of control programs. Proceedings of the National Academy of Sciences, USA 94, 338-342.
50. Woolhouse, M. E. J., Haydon, D. T. and Antia, R. (2005). Emerging pathogens: the epidemiology and evolution of species jumps. Trends in Ecology and Evolution 20, 238-244.
51. Yates, A., Antia, R. and Regoes, R. R. (2006). How do pathogen evolution and host heterogeneity interact in disease emergence? Proceedings of the Royal Society B-Biological Sciences 273, 3075-3083.